Variant report

Variant	nsv961163
Chromosome Location	chr19:51971394-51976393
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:51976198-51976551	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:51969441-51971962	K562	blood:	n/a	n/a
3	ARID3A	chr19:51976233-51976587	K562	blood:	n/a	n/a
4	ARID3A	chr19:51972311-51972737	K562	blood:	n/a	n/a
5	ARID3A	chr19:51974344-51975047	K562	blood:	n/a	n/a
6	ATF1	chr19:51976212-51976512	K562	blood:	n/a	n/a
7	ATF1	chr19:51974323-51974655	K562	blood:	n/a	n/a
8	ATF1	chr19:51971241-51971687	K562	blood:	n/a	n/a
9	BACH1	chr19:51974820-51975214	K562	blood:	n/a	n/a
10	BHLHE40	chr19:51976238-51976595	K562	blood:	n/a	n/a
11	BHLHE40	chr19:51971252-51972105	K562	blood:	n/a	n/a
12	BHLHE40	chr19:51974450-51974562	K562	blood:	n/a	n/a
13	CBX3	chr19:51971108-51972140	K562	blood:	n/a	n/a
14	CBX3	chr19:51974177-51974638	K562	blood:	n/a	n/a
15	CCNT2	chr19:51971263-51971935	K562	blood:	n/a	n/a
16	CCNT2	chr19:51974370-51974589	K562	blood:	n/a	n/a
17	CEBPB	chr19:51974336-51974578	K562	blood:	n/a	n/a
18	CEBPB	chr19:51975763-51976401	K562	blood:	n/a	n/a
19	CEBPB	chr19:51974300-51974658	K562	blood:	n/a	n/a
20	CEBPB	chr19:51974185-51974632	K562	blood:	n/a	n/a
21	CEBPB	chr19:51974319-51974608	Hela-S3	cervix:	n/a	n/a
22	CEBPD	chr19:51971143-51971708	K562	blood:	n/a	n/a
23	CTCF	chr19:51976280-51976430	GM12873	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
24	CTCF	chr19:51976221-51976517	MCF-7	breast:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
25	CTCF	chr19:51976050-51976707	K562	blood:	n/a	chr19:51976363-51976384 chr19:51976562-51976580 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976557-51976578 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377 chr19:51976563-51976579
26	CTCF	chr19:51976320-51976470	Hela-S3	cervix:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
27	CTCF	chr19:51976230-51976503	K562	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
28	CTCF	chr19:51975840-51975990	RPTEC	kidney:	n/a	n/a
29	CTCF	chr19:51976300-51976450	GM12874	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
30	CTCF	chr19:51976380-51976530	HAc	cerebellar:	n/a	n/a
31	CTCF	chr19:51975800-51975950	NHLF	lung:	n/a	n/a
32	CTCF	chr19:51976300-51976450	HAc	cerebellar:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
33	CTCF	chr19:51976236-51976519	Pancreas_OC	pancreas:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
34	CTCF	chr19:51976153-51976633	A549	lung:	n/a	chr19:51976363-51976384 chr19:51976562-51976580 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976557-51976578 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377 chr19:51976563-51976579
35	CTCF	chr19:51976212-51976505	GM19238	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
36	CTCF	chr19:51976300-51976450	HEEpiC	esophagus:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
37	CTCF	chr19:51976226-51976504	GM19240	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
38	CTCF	chr19:51976224-51976489	GM10248	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
39	CTCF	chr19:51976300-51976450	WERI-Rb-1	eye:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
40	CTCF	chr19:51976300-51976450	GM12873	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
41	CTCF	chr19:51976220-51976370	NHEK	skin:	n/a	n/a
42	CTCF	chr19:51976150-51976533	H1-hESC	embryonic stem cell:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
43	CTCF	chr19:51976004-51976039	HepG2	liver:	n/a	n/a
44	CTCF	chr19:51976320-51976470	AG04450	lung:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
45	CTCF	chr19:51975985-51976150	Spleen_OC	spleen:	n/a	n/a
46	CTCF	chr19:51976240-51976390	K562	blood:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
47	CTCF	chr19:51975880-51976030	A549	lung:	n/a	n/a
48	CTCF	chr19:51976320-51976470	HCT-116	colon:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
49	CTCF	chr19:51976225-51976501	NHEK	skin:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377
50	CTCF	chr19:51976231-51976467	SK-N-SH_RA	brain:	n/a	chr19:51976363-51976384 chr19:51976366-51976376 chr19:51976364-51976373 chr19:51976362-51976378 chr19:51976361-51976379 chr19:51976364-51976377

No.	Distal block	Cell Line	Cell type
1	chr19:51970891..51972816-chr19:51977892..51980633,2	K562	blood:
2	chr19:51975813..51976889-chr19:52140105..52142089,6	K562	blood:
3	chr19:51974430..51976310-chr19:52037889..52040847,2	K562	blood:
4	chr19:51975902..51976858-chr19:52110641..52111904,7	K562	blood:
5	chr19:51975890..51976812-chr19:52159933..52160756,4	K562	blood:
6	chr19:51974505..51976487-chr19:52010911..52013199,2	K562	blood:
7	chr19:51925342..51926122-chr19:51975926..51976809,2	K562	blood:
8	chr19:51975913..51977254-chr19:52159906..52161263,12	MCF-7	breast:
9	chr19:51975931..51976838-chr19:52160089..52160663,2	MCF-7	breast:
10	chr19:51975869..51976891-chr19:52110720..52111476,3	MCF-7	breast:
11	chr19:51971316..51973681-chr19:51979133..51981319,3	K562	blood:
12	chr19:51975672..51976584-chr19:52164011..52164572,3	MCF-7	breast:
13	chr19:51976250..51976763-chr19:52286398..52287255,2	MCF-7	breast:
14	chr19:51976019..51976960-chr19:52110904..52111829,3	MCF-7	breast:
15	chr19:51943317..51945909-chr19:51971726..51974362,2	K562	blood:
16	chr19:51868665..51871642-chr19:51973620..51976713,3	K562	blood:
17	chr19:51975937..51976795-chr19:52018276..52018797,2	MCF-7	breast:
18	chr19:51976116..51976755-chr19:52018185..52018795,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SIGLEC8-1	chr19:51971614-51971890	NONHSAT067444

Variant related genes	Relation type
SIGLEC26P	TF binding region
CEACAM18	TF binding region
ENSG00000105379	chromatin interactions
ENSG00000269181	chromatin interactions
ENSG00000269580	chromatin interactions
ENSG00000268520	chromatin interactions
ENSG00000213822	chromatin interactions
ENSG00000160318	chromatin interactions
ENSG00000269403	chromatin interactions

Extended variants
information (count: 215 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:215 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35920366	chr19:51971417-51971418	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs578202735	chr19:51971424-51971425	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs551532818	chr19:51971535-51971536	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs181499401	chr19:51971575-51971576	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs569930755	chr19:51971579-51971580	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs563316709	chr19:51971612-51971613	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs575213876	chr19:51971672-51971673	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs542299530	chr19:51971724-51971725	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs560677345	chr19:51971735-51971736	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
10	rs528261166	chr19:51971736-51971737	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
11	rs374272337	chr19:51971748-51971749	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
12	rs564986794	chr19:51971789-51971790	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
13	rs531045551	chr19:51971792-51971793	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
14	rs185648212	chr19:51971814-51971815	Weak transcription Enhancers Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
15	rs551453939	chr19:51971816-51971817	Weak transcription Enhancers Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
16	rs570019330	chr19:51971817-51971818	Weak transcription Enhancers Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
17	rs530841887	chr19:51971821-51971822	Weak transcription Enhancers Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
18	rs368555378	chr19:51971854-51971855	Weak transcription Enhancers Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
19	rs147728804	chr19:51971874-51971875	Weak transcription Enhancers Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
20	rs535183180	chr19:51971880-51971881	Weak transcription Enhancers Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
21	rs79100234	chr19:51971949-51971950	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs191085743	chr19:51971954-51971955	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs569714554	chr19:51971981-51971982	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs144797041	chr19:51971995-51971996	Weak transcription Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs146396755	chr19:51972027-51972028	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs77717173	chr19:51972028-51972029	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs36502	chr19:51972060-51972061	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs535007515	chr19:51972106-51972107	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs36503	chr19:51972137-51972138	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs8107459	chr19:51972161-51972162	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs554204283	chr19:51972210-51972211	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs182920678	chr19:51972227-51972228	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs540011125	chr19:51972290-51972291	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs565106278	chr19:51972293-51972294	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs372538246	chr19:51972342-51972343	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs111654379	chr19:51972352-51972353	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs8107036	chr19:51972372-51972373	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs2607259	chr19:51972397-51972398	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs2607258	chr19:51972427-51972428	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs8106939	chr19:51972438-51972439	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs78166504	chr19:51972459-51972460	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs8106860	chr19:51972463-51972464	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs374754394	chr19:51972474-51972475	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs369727046	chr19:51972495-51972496	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs8106969	chr19:51972497-51972498	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs8107073	chr19:51972540-51972541	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs567713364	chr19:51972564-51972565	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs528616954	chr19:51972571-51972572	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs546843073	chr19:51972572-51972573	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs187515889	chr19:51972601-51972602	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Adrenocortical carcinoma	18281524	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:35 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:51964600-51973000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
2	chr19:51966800-51973400	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr19:51969000-51972600	Enhancers	Primary hematopoietic stem cells	blood
4	chr19:51969200-51971400	Active TSS	K562	blood
5	chr19:51969200-51971800	Enhancers	Monocytes-CD14+_RO01746	blood
6	chr19:51970800-51971800	Enhancers	Primary monocytes fromperipheralblood	blood
7	chr19:51970800-51971800	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
8	chr19:51970800-51971800	Enhancers	Dnd41	blood
9	chr19:51971000-51971800	Bivalent Enhancer	Primary B cells from cord blood	blood
10	chr19:51971000-51971800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr19:51971400-51971800	Flanking Active TSS	K562	blood
12	chr19:51971400-51972000	Active TSS	Duodenum Mucosa	Duodenum
13	chr19:51971600-51972000	Enhancers	Lung	lung
14	chr19:51971800-51972200	Active TSS	K562	blood
15	chr19:51971800-51973000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr19:51971800-51974200	Weak transcription	Primary monocytes fromperipheralblood	blood
17	chr19:51971800-51975000	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr19:51972000-51972200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
19	chr19:51972000-51976000	Weak transcription	Duodenum Mucosa	Duodenum
20	chr19:51972200-51973400	Flanking Active TSS	K562	blood
21	chr19:51972600-51976400	Weak transcription	Primary hematopoietic stem cells	blood
22	chr19:51973000-51973800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
23	chr19:51973400-51973600	Enhancers	K562	blood
24	chr19:51973600-51974000	Flanking Active TSS	K562	blood
25	chr19:51974000-51974400	Enhancers	K562	blood
26	chr19:51974400-51974600	Enhancers	Primary monocytes fromperipheralblood	blood
27	chr19:51974400-51974800	Flanking Active TSS	K562	blood
28	chr19:51974800-51976000	Enhancers	K562	blood
29	chr19:51975000-51976600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
30	chr19:51975800-51981600	Enhancers	Fetal Intestine Small	intestine
31	chr19:51975800-51981800	Enhancers	Fetal Intestine Large	intestine
32	chr19:51976000-51976400	Flanking Active TSS	Duodenum Mucosa	Duodenum
33	chr19:51976000-51976800	Weak transcription	Gastric	stomach
34	chr19:51976000-51977400	Genic enhancers	K562	blood
35	chr19:51976200-51976800	Enhancers	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links